Efficacy and safety of nanoparticle albumin‐bound paclitaxel monotherapy after immune checkpoint inhibitor administration for advanced non‐small cell lung cancer: A multicenter Phase 2 clinical trial

BACKGROUND: Whether immunotherapy improves the efficacy or worsens adverse events of subsequent chemotherapy remains unclear. We performed a Phase 2 study to evaluate the efficacy and safety of nanoparticle albumin‐bound paclitaxel (nab‐paclitaxel) as a treatment for advanced non‐small cell lung can...

Descripción completa

Detalles Bibliográficos
Autores principales: Sonoda, Tomoaki, Umeda, Yukihiro, Demura, Yoshiki, Tada, Toshihiko, Nakashima, Koki, Anzai, Masaki, Yamaguchi, Makiko, Shimada, Akikazu, Ohi, Masahiro, Honjo, Chisato, Waseda, Yuko, Akai, Masaya, Ishizuka, Tamotsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315716/
https://www.ncbi.nlm.nih.gov/pubmed/37081729
http://dx.doi.org/10.1002/cam4.5978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315716/
https://www.ncbi.nlm.nih.gov/pubmed/37081729
http://dx.doi.org/10.1002/cam4.5978

Ejemplares similares